Register entry

Kowon International Korea Co., Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
5
Live patents
0
Countries
1
Base
South Korea
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Kowon International Korea Co., Ltd.17-9 Mugeuk-ro 65beon-gil, Geumwang-eup, Eumseong, Chungbuk 27632, Korea, South (KOR)Active ingredient (API) manufacture3009717335695097716
Catalogue

Drug listings by form and route

5

5 active NDC listings: 5 human otc drug. By marketing category: DRUG FOR FURTHER PROCESSING 5.

Dosage formNDCs
liquid5
RouteNDCs
Labeller name on the listingNDCs
kowon international korea co.ltd5
Catalogue

Marketed products

5
BrandGeneric nameForm / routeNDC
-Titanium Dioxideliquid73493-030DRUG FOR FURTHER PROCESSING
-Titanium Dioxideliquid73493-040DRUG FOR FURTHER PROCESSING
-Titanium Dioxideliquid73493-050DRUG FOR FURTHER PROCESSING
-Zinc Oxideliquid73493-010DRUG FOR FURTHER PROCESSING
-Zinc Oxideliquid73493-020DRUG FOR FURTHER PROCESSING
Compare

Comparable companies in South Korea

Enquiry

Common questions

Is Kowon International Korea Co., Ltd. FDA approved?
Kowon International Korea Co., Ltd. holds 1 FDA-registered establishment in South Korea. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Kowon International Korea Co., Ltd.'s drugs manufactured?
The FDA register lists Chungbuk 27632. Registered operations: active ingredient (API) manufacture.
What drugs does Kowon International Korea Co., Ltd. make?
5 products are listed under Kowon International Korea Co., Ltd. in the openFDA NDC Directory, most often as liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.